{
    "2020-07-15": [
        [
            {
                "time": "",
                "original_text": "生物制品Ⅱ行业投资策略报告：狂犬疫苗供不应求 提价显著增厚业绩",
                "features": {
                    "keywords": [
                        "生物制品",
                        "狂犬疫苗",
                        "供不应求",
                        "提价",
                        "增厚业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物、爱尔眼科、康泰生物、沃森生物集体大涨并创新高，力撑创业板指",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "爱尔眼科",
                        "康泰生物",
                        "沃森生物",
                        "集体大涨",
                        "创新高",
                        "创业板指"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "医疗健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}